GlobalData on MSN
FDA puts REGENXBIO gene therapy trials on hold after brain tumour
A five-year-old patient dosed with RGX-111 has developed a brain tumour four years after being dosed with the gene therapy.
Tens of thousands of cholesterol medication bottles are being recalled nationwide due to manufacturing issues that could ...
By Kamal Choudhury Jan 30 (Reuters) - Shares of Corcept Therapeutics fell 16% on Friday after a corrected "complete response ...
Keurig Dr Pepper has recalled about 80,640 McCafe Premium Roast Decaf Coffee K-Cup Pods because the pods may contain caffeine ...
The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for ...
Almost 85,000 bottles of Parodontax Active Gum Health mouthwash have been recalled nationwide. The bottles may have missing ...
The Food and Drug Administration paused trials for two experimental gene therapies from Regenxbio after one child developed a ...
The Food and Drug Administration (FDA) has granted Fast Track designation to QTX-2101, an oral formulation of arsenic trioxide, for the treatment of acute promyelocytic leukemia (APL), an aggressive ...
DOJ accuses Louisiana AG, alleged victim of abortion coercion of trying to "short circuit" FDA's review of mifepristone's ...
The target action date for orforglipron is now April 10.
The FDA accepted an application for ivonescimab with chemotherapy for patients with lung cancer driven by EGFR changes after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results